Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
27.22
-1.47 (-5.12%)
At close: Mar 3, 2026, 4:00 PM EST
27.13
-0.09 (-0.33%)
After-hours: Mar 3, 2026, 7:31 PM EST
Beam Therapeutics Stock Forecast
Stock Price Forecast
The 15 analysts with 12-month price forecasts for Beam Therapeutics stock have an average target of 49.13, with a low estimate of 21 and a high estimate of 80. The average target predicts an increase of 80.49% from the current stock price of 27.22.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Beam Therapeutics stock from 16 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 6 | 6 |
| Buy | 4 | 5 | 5 | 6 | 7 | 7 |
| Hold | 2 | 2 | 2 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 12 | 12 | 14 | 16 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Hold Maintains $22 → $26 | Hold | Maintains | $22 → $26 | -4.48% | Feb 25, 2026 |
| Wedbush | Wedbush | Buy Maintains $57 → $65 | Buy | Maintains | $57 → $65 | +138.80% | Feb 25, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Initiates $74 | Strong Buy | Initiates | $74 | +171.86% | Feb 20, 2026 |
| Bernstein | Bernstein | Buy Maintains $37 → $41 | Buy | Maintains | $37 → $41 | +50.62% | Jan 21, 2026 |
| UBS | UBS | Hold Initiates $28 | Hold | Initiates | $28 | +2.87% | Jan 7, 2026 |
Financial Forecast
Revenue This Year
48.28M
from 139.74M
Decreased by -65.45%
Revenue Next Year
65.57M
from 48.28M
Increased by 35.80%
EPS This Year
-4.67
from -0.81
EPS Next Year
-4.72
from -4.67
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 115.5M | 191.5M | |||
| Avg | 48.3M | 65.6M | |||
| Low | 31.4M | 29.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -17.3% | 296.6% | |||
| Avg | -65.5% | 35.8% | |||
| Low | -77.6% | -38.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -3.71 | -3.40 | |||
| Avg | -4.67 | -4.72 | |||
| Low | -5.31 | -6.06 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.